Literature DB >> 7842107

[Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].

J C Netter1, G Cossarizza, C Narcy, P Hubert, H Ogier, Y Revillon, D Rabier, J M Saudubray.   

Abstract

BACKGROUND: Dietary treatment of maple syrup urine disease remains difficult; chronic nutritional support in the child does not always avoid acute crises so that liver transplantation may represent an alternate choice in some cases. CASE REPORTS: Two gypsy cousins were born by an interval of 4 days; both had maple syrup urine disease and were similarly treated from the first days of life. They were given exchange transfusions followed by diet restricted in the branched chain amino acids, maintaining normal growth and plasma leucine concentrations under 7 mg/100 ml. Laura, at 10 years, was retarded at school. Compliance to school attendance was limited by her diet problems. Helen suffered at 7 yr 3 mo from liver failure due to hepatitis A virus infection which required liver transplantation. Protein intake was normal 1 week later. At 10 years, she presented with the same degree of school retardation as her cousin, and was placed in the same class.
CONCLUSION: Liver transplantation may be effective for treating metabolic problems in MSVD without significative difference between outcome post classic treatment or post liver transplantation.

Entities:  

Mesh:

Year:  1994        PMID: 7842107

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  5 in total

1.  Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.

Authors:  A Bodner-Leidecker; U Wendel; J M Saudubray; P Schadewaldt
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

2.  Successful domino liver transplantation in maple syrup urine disease using a related living donor.

Authors:  F H Feier; I K Miura; E A Fonseca; G Porta; R Pugliese; A Porta; I V D Schwartz; A V B Margutti; J S Camelo; S N Yamaguchi; A T Taveira; H Candido; M Benavides; V Danesi; T Guimaraes; M Kondo; P Chapchap; J Seda Neto
Journal:  Braz J Med Biol Res       Date:  2014-04-25       Impact factor: 2.590

Review 3.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982

4.  Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.

Authors:  Kristen J Skvorak; Harbhajan S Paul; Kenneth Dorko; Fabio Marongiu; Ewa Ellis; Donald Chace; Carolyn Ferguson; K Michael Gibson; Gregg E Homanics; Stephen C Strom
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

5.  Production and characterization of murine models of classic and intermediate maple syrup urine disease.

Authors:  Gregg E Homanics; Kristen Skvorak; Carolyn Ferguson; Simon Watkins; Harbhajan S Paul
Journal:  BMC Med Genet       Date:  2006-03-31       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.